You are here: Industry Insights > South Korea

News List

South Korea grants approval to Novavax Covid-19 vaccine Pharmaceutical-Technology
January 13, 2022
SK bioscience will handle the manufacturing and commercialisation of the vaccine in South Korea.
S Korea authorises use of Novavax COVID-19 vaccine ExpressPharma
January 13, 2022
South Korean vaccine developer SK Bioscience said it will produce the Novavax vaccine
South Korea gives EUA for Pfizer’s oral coronavirus treatment ExpressPharma
December 28, 2021
South Korea authorised for emergency use Pfizer’s antiviral pills targeting COVID-19 as the first of its kind to be introduced in South Korea, said the Ministry of Food and Drug Safety.
S Korea approves Moderna’s COVID-19 vaccine expresspharma
May 24, 2021
The green light comes after two of three expert panels recommended approval be granted for the two-dose vaccine based on safety and efficacy in late-stage trials in the United States.
Seegene's COVID-19 test with saliva sample collection feature now available in Europe prnewswire
January 07, 2021
South Korea's biotechnology company specializing in molecular diagnostics, Seegene Inc. (KQ096530) said Tuesday that it has CE-IVD marked the saliva-based testing application for Allplex™ SARS-CoV-2 Assay and Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay ...
What the rest of the world can learn from South Korea's COVID-19 response worldpharmanews
August 12, 2020
As the world continues to closely monitor the newest coronavirus outbreak, the government of South Korea has been able to keep the disease under control without paralyzing the national health and economic systems.
Nicox signs agreement for ZERVIATE in South Korea biospectrumasia
December 18, 2019
Samil Pharmaceutical will receive exclusive rights to develop and commercialize ZERVIATE in South Korea, where the market for allergic conjunctivitis was worth nearly €31 million for the 12 months to Q3 2019.
Novotech highlights South Korea's plans on clinical trials advancements biospectrumasia
September 16, 2019
Novotech provides clinical development services across all clinical trial phases and therapeutic areas including: feasibility assessments; ethics committee and regulatory submissions, data management, statistical analysis, medical monitoring, safety servi
Samsung BioLogics strikes back, filing lawsuit over criminal penalties imposed by Korean regulators fiercepharma
December 06, 2018
Two weeks after South Korean financial regulators imposed a laundry list of penalties on Samsung BioLogics for alleged accounting missteps related to its Biogen-partnered joint venture, the company has launched a counterattack.
CHA Biotech receives patent for stem cell culture medium biospectrumasia
February 26, 2018
CHA Biotech and CHA BIO F&C each own 50 percent of the patent.

Previous page 1 2 Next page